Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00294398 · ClinicalTrials.gov registry record · NA
Inhaled Corticosteroids After a Pediatric Emergency Visit for Asthma
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
NCT00294398 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 152 participants.
The verdict
NCT00294398, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
Study Summary
Specific Aim: To determine whether a prescription for Inhaled Corticosteroids (ICS) added to standard Emergency Department (ED) discharge therapy for young children with persistent asthma symptoms increases ICS use and improves symptoms and quality of life over the months following the ED visit. Hypotheses: In a cohort of pediatric patients with persistent asthma discharged from the ED after an acute asthma exacerbation, a prescription for ICS will: 1. Improve usage of ICS as measured by refill of a prescription within the first 2 months after the ED visit 2. Improve symptom severity at two weeks after an ED visit as measured by days of cough, wheeze, missed school, daycare or work 3. Improve patient and caregiver asthma-related quality of life during the 2 months following an ED visit measured by asthma Health Related Quality of Life (HRQL) 4. Improve asthma control at 2 months as measured by a validated asthma instrument
Interventions
- OTHER ICS Prescription + Standard Asthma ED Discharge Therapy
- OTHER Standard Asthma ED Discharge Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2006-03 |
| Est. Completion | 2009-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00294398
The ClinicalTrials.gov registry entry for NCT00294398 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ICS Prescription + Standard Asthma ED Discharge Therapy is the first listed.
NCT00294398 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00294398 about?
NCT00294398 is a clinical study titled "Inhaled Corticosteroids After a Pediatric Emergency Visit for Asthma". Specific Aim: To determine whether a prescription for Inhaled Corticosteroids (ICS) added to standard Emergency Department (ED) discharge therapy for young children with persistent asthma symptoms increases ICS use and improves symptoms and quality of life over the months following the ED visit. H...
What is the current status of trial NCT00294398?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2006-03. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00294398?
The interventions under investigation include: ICS Prescription + Standard Asthma ED Discharge Therapy (OTHER), Standard Asthma ED Discharge Therapy (OTHER).
Who is sponsoring clinical trial NCT00294398?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.